About us Contact Terms of Use Data Sources Publications FAQ
RAN logo

RAN

GTP-binding nuclear protein Ran

Expression

StudyTumor samplesMaxQ3Q2Q1MinNormal samplesMaxQ3Q2Q1MinLog2 (T vs N)
Adrenocortical (ACC) 77 3.29 2.78 2.68 2.51 2.20 126 3.00 2.46 2.39 2.31 -0.09 0.29
Bladder (BLCA) 406 3.07 2.62 2.50 2.40 1.94 9 2.41 2.34 2.26 2.20 2.12 0.25
Breast (BRCA) 1067 2.89 2.46 2.38 2.29 1.80 178 2.72 2.32 2.18 2.11 1.96 0.20
Cervical (CESC) 297 3.03 2.65 2.56 2.47 2.24 10 2.44 2.42 2.18 2.12 2.03 0.39
Cholangiocarcinoma (CHOL) 36 2.67 2.50 2.42 2.35 2.10 0
Colon (COAD) 443 3.30 2.79 2.67 2.55 2.08 166 2.55 2.32 2.25 2.19 -0.09 0.42
B-cell lymphoma (DLBC) 42 3.24 2.98 2.85 2.75 2.53 337 2.75 2.34 2.26 2.18 1.79 0.59
Esophageal (ESCA) 142 2.70 2.48 2.39 2.29 2.06 271 2.77 2.54 2.48 2.40 -0.09 -0.09
Glioblastoma (GBM) 160 2.87 2.53 2.44 2.37 2.20 214 2.54 2.21 2.17 2.13 -0.09 0.28
Head and neck (HNSC) 432 3.08 2.72 2.63 2.53 2.29 55 2.62 2.27 2.18 2.09 2.01 0.45